Clinical Trial Update: Seroprevalence of Hepatitis E in People With an Organ Transplant

View source ↗

Summary

A completed clinical trial studying the seroprevalence of Hepatitis E among organ transplant recipients, sponsored by NIDDK.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis E

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Hepatitis E | Status: COMPLETED